The mitochondrial organelle and the heart;La mitocondria y el corazón

Revista Espanola de Cardiologia

Volumn 55, Issue 12, 2002, Pages 1293-1310

  Marín García, José ^a   Goldenthal, Michael J ^a  

^a Molecular Cardiol/Neuromusc Inst   (United States)

Author keywords

Apoptosis; Cardiotoxicity; Dilated cardiomyopathy; Gene therapy; Hypertrophic cardiomyopathy; Ischemic cardiomyopathy; Mitochondria; Stem cells

Indexed keywords

ALCOHOL; ASCORBIC ACID; DOXORUBICIN; MITOCHONDRIAL DNA; RIBOFLAVIN; THIAMINE; VITAMIN K GROUP;

AGING; ALCOHOLIC CARDIOMYOPATHY; BIOENERGY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENVIRONMENTAL DISEASE; FATTY ACID OXIDATION; GENE MUTATION; HEART DEVELOPMENT; HEART DILATATION; HEART DISEASE; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MYOCARDITIS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; REVIEW; SUDDEN DEATH;

EID: 1942512393     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(02)76802-4     Document Type: Review

References (157)

1. Anderson S, Bankier AT, Barrell BG, De Bruijn MHL, Coulson AR, Drouin J, et al. Sequence and organization of human mitochondrial genome. Nature 1981;290:457-65.
2. Attardi G, Schatz G. Biogenesis of mitochondria. Annu Rev Cell Biol 1988;4:289-333.
3. Shadel GS, Clayton DA. Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 1997;66:409-35.
4. Lopaschuk GD, Collins-Nakai RL, Itoi T. Developmental changes in energy substrate use by the heart. Cardiovasc Res 1992; 26:1172-80.
5. Sack MN, Harrington LS, Jonassen AK, Mjos OD, Yellon DM. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats. Cardiovasc Drugs Ther 2000; 14:31-9.
6. Brown NF, Weis BC, Husti JE, Foster DW, McGarry JD. Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 1995;270:8952-7.
7. Cook GA, Edwards TL, Jansen MS, Bahouth SW, Wilcox HG, Park EA. Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart. J Mol Cell Cardiol 2001;33:317-29.
8. Van Nieuwenhoven FA, Willemsen PH, Van der Vusse GJ, Glatz JF. Co-expression in rat heart and skeletal muscle of four genes coding for proteins implicated in long-chain fatty acid uptake. Int J Biochem Cell Biol 1999;31:489-98.
9. Tiivel T, Kadaya L, Kuznetsov A, Kaambre T, Peet N, Sikk P, et al. Developmental changes in regulation of mitochondrial respiration by ADP and creatine in rat heart in vivo. Mol Cell Biochem 2000;208:119-28.
10. Hoerter JA, Kuznetsov A, Ventura-Clapier R. Functional development of the creatine kinase system in perinatal rabbit heart. Circ Res 1991;69:665-76.
11. Marín-García J, Ananthakrishnan R, Goldenthal MJ. Human mitochondrial function during cardiac growth and development. Mol Cell Biochem 1998;179:21-6.
12. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci 2000;25:502-8.
13. Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem 2001;276:23357-61.
14. Paradies G, Ruggiero FM. Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria. Biochim Biophys Acta 1990;1016:207-21.
15. McMillin JB, Taffet GE, Taegtmeyer H, Hudson EK, Tate CA. Mitochondrial metabolism and substrate competition in the aging Fischer rat heart. Cardiovasc Res 1993:27:2222-8.
16. López Jiménez JA, Bordoni A, Lorenzini A, Rossi CA, Biagi PL, Hrelia S. Linoleic acid metabolism in primary cultures of adult rat cardiomyocytes is impaired by aging. Biochem Biophys Res Commun 1997;237:142-5.
17. Costell M, O'Connor JE, Grisolia S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun 1989 161:1135-43.
18. Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989;1:642-5.
19. Hattori K, Tanaka M, Sugiyama S, Obayashi T, Ito T, Satake T, et al. Age-dependent increase in deleted mitochondrial DNA in the human heart:possible contributory factor in presbycardia. Am Heart J 1991;121:1735-42.
20. Muller-Hocker J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart -an age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 1989;134:1167-73.
21. Ames BN, Shigenaga MK, Hagen TM. Mitochondrial decay in aging. Biochim Biophys Acta 1995;1272:165-70.
22. Miro O, Casademont J, Casals E, Perea M, Urbano-Márquez A, Rustin P, et al. Aging is associated with increased lipid peroxidation in human hearts, but not with mitochondrial respiratory chain enzyme defects. Cardiovasc Res 2000;47:624-31.
23. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia -reperfusion, aging, and heart failure. J Mol Cell Cardiol 2001;33: 1065-89.
24. Lucas DT, Szweda LI. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci USA 1999; 96:6689-9.
25. Rustin P, Lebidois J, Chretien D, Bourgeron T, Piechaud JF, Rotig A, et al. Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies. J Pediatr 1994;124:224-8.
26. Buchwald A, Till H, Unterberg C, Oberschmidt R, Figulla HR, Wiegand V. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur Heart J 1990;11:509-16.
27. Marín-García J, Goldenthal MJ, Pierpont ME, Ananthakrishnan R. Impaired mitochondrial function in idiopathic dilated cardiomyopathy: biochemical and molecular analysis. J Card Fail 1995;1:285-91.
28. Marín-García J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ, Pérez-Atayde A. Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy. J Inherit Metab Dis 1997;20:674-80.
29. Taniike M, Fukushima H, Yanagihara I, Tsukamoto H, Tanaka J, Fujimura H, et al. Mitochondrial tRNA Ile mutation in fatal cardiomyopathy. Biochem Biophys Res Commun 1992;186:47-53.
30. Silvestri G, Santorelli FM, Shanske S, Whitley CB, Schimmenti LA, Smith SA, et al. A new mtDNA mutation in the tRNA LEU(UUR) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37-43.
31. Santorelli FM, Mak SC, Vázquez-Acevedo M, González-Astiazaran A, Ridaura-Sanz C, González-Halphen D, et al. A novel mtDNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995;216: 835-40.
32. Santorelli FM, Mak SC, El-Schahawi M, Casali C, Shanske S, Baram TZ, et al. Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA Lys gene (G8363). Am J Hum Genet 1996;58:933-9.
33. Merante F, Tein I, Benson L, Robinson BH. Maternally inherited cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA Gly gene. Am J Hum Genet 1994;55:437-46.
34. Zeviani M, Gellera C, Antozzi C, Rimoldi M, Morandi L, Villani F, et al. Maternally inherited myopathy and cardiomyopathy:association with mutation in mitochondrial DNA tRNA Leu. Lancet 1991;338:143-7.
35. Casali C, Santorelli FM, D'Amati G, Bernucci P, DeBiase L, DiMauro S. A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995; 213:588-93.
36. McFarland R, Clark KM, Morris AA, Taylor RW, Macphail S, Lightowlers RN, et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002;30: 145-6.
37. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131-49.
38. Santorelli FM, Tanji K, Manta P, Casali C, Krishna S, Hays AP, et al. Maternally inherited cardiomyopathy: an atypical presentation of the mtDNA 12S rRNA gene A 1555G mutation. Am J Hum Genet 1999;64:295-300.
39. Arbustini E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol l998; 153:1501-10.
40. Li YY, Maisch B, Rose ML, Hengstenberg C. Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. J Mol Cell Cardiol 1997;29:2699-709.
41. Marín-García J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME. The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations. J Card Fail 2000;6:321-9.
42. Shoffner JM, Wallace DC. Heart disease and mitochondrial DNA mutations. Heart Dis Stroke 1992;1:235-41.
43. Pastores GM, Santorelli FM, Shanske S, Gelb BD, Fyfe B, Wolfe D, et al. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial point mutation (T8993G). Am J Med Genet 1994;50:265-71.
44. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, et al. Cardiac involvement in mitochondrial diseases:a study of 17 patients with mitochondrial DNA defects. Circulation 1995;91:955-61.
45. Graf WD, Marín-García J, Gao HG, Pizzo S, Naviaux RK, Markusic D, et al. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys)mutation. J Child Neurol 2000; 15:357-61.
46. Matthews PM, Marchington DR, Squier M, Land J, Brown R, Brown GK. Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol 1993;33:652-5.
47. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-9.
48. Filiano JJ, Goldenthal MJ, Mamourian AC, Hall CC, Marín-García J. Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol 2002;26:239-42.
49. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of mtDNA in patients with mitochondrial myopathies. Nature 1988;331: 717-9.
50. Zeviani M, Moraes CT, DiMauro S, Nakase H, Bonilla E, Schon EA, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-46.
51. Muller-Hocker J, Jacob U, Seibel P. The common 4977 base pair deletion of mitochondrial DNA preferentially accumulates in the cardiac conduction system of patients with Kearns-Sayre syndrome. Mod Pathol 1998;11:295-301.
52. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996;46:1329-34.
53. Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992;340: 1319-20.
54. Marín-García J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME, Fricker FJ, Lipshultz S, et al. Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 1996;31:306-14.
55. Simonetti S, Chen X, DiMauro S, Schon E. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1992; 1180:113-22.
56. Marín-García J, Ananthakrishnan R, Goldenthal MJ, Pierpont ME. Biochemical and molecular basis for mitochondrial cardiomyopathy in neonates and children. J Inherit Metab Dis 2000;23:625-33.
57. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nature Med 1995;1:417-22.
58. Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett JD. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of 6 cases. Ann Intern Med 1992;116:311-13.
59. Huizing M, Iacobazzi V, Ijlst L, Savelkoul P, Ruitenbeek W, van den Heuvel L, et al. Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 1997;61:1239-45.
60. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996;271:1423-7.
61. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE, et al. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 1999;23:333-7.
62. Sue CM, Karadimas C, Checcarelli N, Tanji K, Papadopoulou LC, Pallotti F, et al. Differential features of patients with mutations in two COX assembly genes, SURF-1 and SCO2. Ann Neurol. 2000;47:589-95.
63. Kelly DP, Strauss AW. Inherited Cardiomyopathies. N Eng J Med 1994;330:913-9.
64. Strauss AW, Powell CK, Hale DE, Anderson MM, Ahuja A, Brackett JC, et al. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency: causing cardiomyopathy and sudden death in childhood. Proc Natl Acad Sci USA 1995 92:10496-500.
65. Rocchiccioli F, Wanders RJ, Aubourg P, Vianey-Liaud C, Ijlst L, Fabre M, et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990;28:657-62.
66. Tein I, Haslam RH, Rhead WJ, Bennett MJ, Becker LE, Vockley J. Short-chain acyl-CoA dehydrogenase deficiency:a cause of ophthalmoplegia and multicore myopathy. Neurology 1999; 52:366-72.
67. Stanley CA, Treem WR, Hale DE, Coates PM. A genetic defect in carnitine transport causing primary carnitine deficiency. Prog Clin Biol Res 1990;321:457-64.
68. Brackett JC, Sims HF, Rinaldo P, Shapiro S, Powell CK, Bennett MJ, et al. Two subunit donor splice site mutations cause human trifunctional protein deficiency. J Clin Invest 1995;95: 2076-82.
69. Bonnet D, Martin D, de Lonlay P, Villain E, Jouvet P, Rabier D, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 1999;100:2248-53.
70. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest 1989;83:927-36.
71. Tripp ME. Developmental cardiac metabolism in health and disease. Pediatr Cardiol 1989;10:150-8.
72. D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997;61:862-7.
73. Bissler JJ, Tsoras M, Goring HH, Hug P, Chuck G, Tombragel E, et al. Infantile dilated x-linked cardiomyopathy, g4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Lab Invest 2002;82: 335-44.
74. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 2000;279:378-82.
75. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 1993;90:3993-7.
76. Thompson CH, Kemp GJ, Taylor DJ, Conway M, Rajagopalan B, O'Donoghue A, et al. Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy. Heart 1997:78: 177-81.
77. Arbustini E, Fasani R, Morbini P, Diegoli M, Grasso M, Dal Bello B, et al. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart 1998;80:548-58.
78. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000;150:1283-98.
79. Corbucci GG. Adaptive changes in response to acute hypoxia, ischemia and reperfusion in human cardiac cell. Minerva Anestesiol 2000:66:523-30.
80. Ylitalo K, Ala-Rami A, Vuorinen K, Peuhkurinen K, Lepojarvi M, Kaukoranta P, et al. Reversible ischemic inhibition of F(1)F(0)-ATPase in rat and human myocardium. Biochim Biophys Acta 2001 1504:329-39.
81. Corral-Debrinski M, Stepien G, Shoffner JM, Lott MT, Kanter K, Wallace DC. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. JAMA 1991;266:1812-6.
82. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero FM. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med 1999;27:42-50.
83. Gottleib RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-28.
84. Sammut IA, Jayakumar J, Latif N, Rothery S, Severs NJ, Smolenski RT, et al. Heat stress contributes to the enhancement of cardiac mitochondrial complex activity. Am J Pathol 2001; 158:1821-31.
85. Ghosh S, Standen NB, Galinanes M. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res 2000;45:934-40.
86. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2 related proteins. J Exp Med 1998;187:1261-71.
87. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998;281:2027-31.
88. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998;1366:177-96.
89. Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J NeuroSci 1996;16:6125-33.
90. Szewczyk A, Wojtczak L. Mitochondria as a pharmacological target. Pharmacol Rev 2002;54:101-27.
91. Wallace KB, Starkov AA. Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol 2000:40:353-88.
92. Abdel-Aleem S, el-Merzabani MM, Sayed-Ahmed M, Taylor DA, Lowe JE. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes. J Mol Cell Cardiol 1997;29:789-97.
93. Serrano J, Palmeira CM, Kuehl DW, Wallace KB. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim Biophys Acta 1999;1411:201-5.
94. Zhou S, Heller LJ, Wallace KB. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. Toxicol Appl Pharmacol 2001;175:60-7.
95. Solem LE, Henry TR, Wallace KB. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol 1994;129:214-22.
96. Adachi K, Fujiura Y, Mayumi F, Nozuhara A, Sugiu Y, Sakanashi T, et al. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. Biochem Biophys Res Commun 1993;195:945-51.
97. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest 1996;98:1253-60.
98. Shneyvays V, Mamedova L, Zinman T, Jacobson K, Shainberg A. Activation of A (3) adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol 2001;33: 1249-61.
99. Sayed-Ahmed MM, Salman TM, Gaballah HE, Abou El-Naga SA, Nicolai R, Calvani M. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy. Pharmacol Res 2001;43:513-20.
100. Wang GW, Klein JB, Kang YJ. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001;298: 461-8.
101. Schulze K, Schultheiss HP. The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J 1995;16 (Suppl O):64-7.
102. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and mortality among women. N Engl J Med 1995;332:1245-50.
103. Marín-García J, Ananthakrishnan R, Goldenthal MJ. Heart mitochondria response to alcohol is different than brain and liver. Alcohol Clin Exp Res 1995;19:1463-6.
104. Siddiq T, Salisbury JR, Richardson PJ, Preedy VR. Synthesis of ventricular mitochondrial proteins in vivo: effect of acute ethanol toxicity. Alcohol Clin Exp Res 1993;17:894-9.
105. Beckemeier ME, Bora PS. Fatty acid ethyl esters: potentially toxic products of myocardial ethanol metabolism. J Mol Cell Cardiol 1998;30:2487-94.
106. Schoppet M, Maisch B. Alcohol and the heart. Herz 2001;26: 345-52.
107. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997;16:226-34.
108. Lebovitz RM, Zhang H, Vogel H, Cartwright Jr, Dionne L, Lu N, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 1996;93:9782-7.
109. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1995;11:376-81.
110. Djouadi F, Brandt JM, Weinheimer CJ, Leone TC, González FJ, Kelly DP. The role of the peroxisome proliferator-activated receptor alpha (PPARα) in control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 1999;60:339-43.
111. Ibdah JA, Paul H, Zhao Y, Binford S, Salleng K, Cline M, et al. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest 2001;107: 1403-9.
112. Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet 1999;21:133-7.
113. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 2001;27: 181-6.
114. Li H, Wilhelmsson H, Hanson A, Thoren P, Duffy J, Rustin P, et al. Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. Proc Natl Acad Sci USA 2000;97:3467-72.
115. Radford NB, Wan B, Richman A, Szczepaniak LS, Li JL, Li K, et al. Cardiac dysfunction in mice lacking cytochrome-c oxidase subunit VIaH. Am J Physiol Heart Circ Physiol 2002;282:H726-33.
116. Inoue K, Nakada K, Ogura A, Isobe K, Goto Y, Nonaka I, et al. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 2000;26:176-81.
117. Nakada K, Inoue K, Chen CS, Nonaka I, Goto Y, Ogura A, et al. Correlation of functional and ultrastructural abnormalities of mitochondria in mouse heart carrying a pathogenic mutant mtDNA with a 4696-bp deletion. Biochem Biophys Res Commun 2001;288:901-7.
118. Nakada K, Inoue K, Ono T, Isobe K, Ogura A, Goto YI, et al. Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med 2001;7:934-40.
119. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002;109:121-30.
120. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000;106:847-56.
121. Melov S, Schneider JA, Day BJ, Hinerfeld D, Coskun P, Mirra SS, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat Genet 1998;18:159-63.
122. Marín-García J, Ananthakrishnan R, Goldenthal MJ, Filiano JJ Pérez-Atayde A. Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy. Pediatrics 1999;103:456-9.
123. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy patient mitochondria. Mol Cell Biol 1991;11:2236-44.
124. Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999;22:488-502.
125. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and mito-chondrial DNA mutations: diagnosis and treatment. Annu Rev Nutr 1994;14:535-68.
126. Langsjuen P, Vadhanavikit S, Folkers K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and cross-over trial with coenzyme Q10. Proc Natl Acad Sci USA 1985;82:4240-4.
127. Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 1999;354:477-9.
128. Lerman-Sagie T, Rustin P, Lev D, Yanoov M, Leshinsky-Silver E, Sagie A, et al. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone. J Inherit Metab Dis 2001;24:28-34.
129. Bonnefont JP, Demaugre F, Prip-Buus C, Saudubray JM, Brivet M, Abadi N, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab 1999;68:424-40.
130. Brown-Harrison MC, Nada MA, Sprecher H, Vianey-Saban C, Farquhar J Jr, Gilladoga AC, et al. Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy. Biochem Mol Med 1996;58:59-65.
131. Pierpont ME, Breningstall GN, Stanley CA, Singh A. Familial carnitine transporter defect: a treatable cause of cardiomyopathy in children. Am Heart J 2000;139:S96-S106.
132. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG. PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol 1999; 276:H149-58.
133. Pollitt RJ. Disorders of mitochondrial long-chain fatty acid oxidation. J Inherit Metab Dis 1995;18:473-90.
134. Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, Nickles RJ, et al. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 2001;103:2441-6.
135. Doetschman T, Shull M, Kier A, Coffin JD. Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders. Hypertension 1993;22:618-29.
136. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000;14:2540-8.
137. Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G, et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 1997;29:1525-39.
138. Bremer S, Worth AP, Paparella M, Bigot K, Kolossov E, Fleischmann BK, et al. Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicol In Vitro 2001;15:215-23.
139. Sligh JE, Levy SE, Waymire KG, Allard P, Dillehay DL, Nusinowitz S, et al. Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc Natl Acad Sci USA 2000;97:14461-6.
140. Zullo SJ. Gene therapy of mitochondrial DNA mutations: a brief, biased history of allotopic expression in mammalian cells. Semin Neurol 2001;21:327-35.
141. Geromel V, Cao A, Briane D, Vassy J, Rotig A, Rustin P, et al. Mitochondria transfection by oligonucleotides containing a signal peptide and vectorized by cationic liposomes. Antisense Nucleic Acid Drug Dev 2001;11:175-80.
142. Taylor RW, Wardell TM, Lightowlers RN, Turnbull DM. Molecular basis for treatment of mitochondrial myopathies. Neurol Sci 2000;21:S909-12.
143. Weissig V, Torchilin VP. Towards mitochondrial gene therapy: DQAsomes as a strategy. J Drug Target 2001;9:1-13.
144. Manfredi G, Fu J, Ojaimi J, Sadlock JE, Kwong JQ, Guy J, et al. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet 2002;30:394-9.
145. Kawarai T, Kawakami H, Kozuka K, Izumi Y, Matsuyama Z, Watanabe C, et al. A new mitochondrial DNA mutation associated with mitochondrial myopathy: tRNA (Leu) (UUR) 3254C-to-G. Neurology 1997;49:598-600.
146. Grasso M, Diegoli M, Brega A, Campana C, Tavazzi L, Arbustini E. The mitochondrial DNA mutation T12297C affects a highly conserved nucleotide of tRNA (Len (CUN)) and is associated with dilated cardiomyopathy. Eur J Hum Genet 2001;9: 311-5.
147. Tanaka M, Ino H, Ohno K, Hattori K, Sato W, Ozawa T, et al. Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 1990;336:1452.
148. Merante F, Myint T, Tein I, Benson L, Robinson BH. An additional mitochondrial tRNA (Ile)point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat 1996;8:216-22.
149. Corona P, Lamantea E, Greco M, Carrara F, Agostino A, Guidetti D, et al. Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol 2002;51: 118-22.
150. Akita Y, Koga Y, Iwanaga R, Wada N, Tsubone J, Fukuda S, et al. Fatal hypertrophic cardiomyopathy associated with an A8296G mutation in the mitochondrial tRNA(Lys)gene. Hum Mutat 2000;15:382.
151. Terasaki F, Tanaka M, Kawamura K, Kanzaki Y, Okabe M, Hayashi T, et al. A case of cardiomyopathy showing progression from the hypertrophic to the dilated form: association of Mt 8348A- >G mutation in the mitochondrial tRNA (Lys) gene with severe ultrastructural alterations of mitochondria in cardiomyocytes. Jpn Circ J 2001;65:691-4.
152. Karadimas C, Tanji K, Geremek M, Chronopoulou P, Vu T, Krishna S, et al. A5814G mutation in mitochondrial DNA can cause mitochondrial myopathy and cardiomyopathy. J Child Neurol 2001;16:531-3.
153. Hsieh RH, Li JY, Pang CY, Wei YH. A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy. J Biomed Sci 2001;8:328-35.
154. Obayashi T, Hattori K, Sugiyama S, Tanaka M, Tanaka T, Itoyama S, et al. Point mutations in mitochondrial DNA in patients with hypertrophic cardiomyopathy. Am Heart J 1992;124:1263-9.
155. Marin-García J, Ananthakrishnan R, Gonzalvo A, Goldenthal MJ. Novel mutations in mitochondrial cytochrome b in a case of fatal post-partum cardiomyopathy. J Inher Metab Dis 1995;18: 77-8.
156. Andreu AL, Checcarelli N, Iwata S, Shanske S, DiMauro S. A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy. Pediatr Res 2000;48:311-4.
157. Valnot I, Kassis J, Chretien D, de Lonlay P, Parfait B, Munnich A, et al. A mitochondrial cytochrome b mutation but no mutations of nuclearly encoded subunits in ubiquinol cytochrome c reductase deficiency. Hum Genet 1999;104:460-6.